J Clin Oncol-话题@MedSci

#J Clin Oncol#

31篇内容 | 944人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2089214, encodeId=6afa20892144e, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>：<a href='/topic/show?id=377096965f6' target=_blank style='color:#2F92EE;'>#长春新碱#</a>-<a href='/topic/show?id=1c855620260' target=_blank style='color:#2F92EE;'>#拓扑替康#</a>-<a href='/topic/show?id=73216852458' target=_blank style='color:#2F92EE;'>#环磷酰胺#</a>用于非转移性<a href='/topic/show?id=f3934e272e8' target=_blank style='color:#2F92EE;'>#尤文氏肉瘤#</a>初始治疗的III期临床试验结果，<a href='/topic/show?id=5f394e273fd' target=_blank style='color:#2F92EE;'>#尤文肉瘤#</a> (EWS) 是一种罕见的<a href='/topic/show?id=5a03104e94f1' target=_blank style='color:#2F92EE;'>#儿童恶性肿瘤#</a>, objectTitle=J Clin Oncol：长春新碱-拓扑替康-环磷酰胺用于非转移性尤文氏肉瘤初始治疗的III期临床试验结果, objectType=article, longId=218769, objectId=9c2d218e69ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211017/1634453597626_2110107.JPG, objectUrl=/article/show_article.do?id=9c2d218e69ce, replyNumber=0, likeNumber=85, createdTime=2022-09-20, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2d218e69ce, moduleTitle=J Clin Oncol：长春新碱-拓扑替康-环磷酰胺用于非转移性尤文氏肉瘤初始治疗的III期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c2d218e69ce)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961865, encodeId=c41a96186550, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=Int J Clin Oncol：研究肯定pertuzumab在日本患者中的疗效，支持其在日本患者人群中的继续研究, objectType=article, longId=203356, objectId=48e320335672, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/097.jpg, objectUrl=/article/show_article.do?id=48e320335672, replyNumber=0, likeNumber=81, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48e320335672, moduleTitle=Int J Clin Oncol：研究肯定pertuzumab在日本患者中的疗效，支持其在日本患者人群中的继续研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48e320335672)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961864, encodeId=d76796186455, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：来那度胺可恢复骨髓增生异常综合征对EPOα的敏感性，改善患者预后, objectType=article, longId=206296, objectId=888e206296e7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/low-t-testosterone-s16-photo-of-red-blood-cells.jpg, objectUrl=/article/show_article.do?id=888e206296e7, replyNumber=0, likeNumber=70, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=888e206296e7, moduleTitle=J Clin Oncol：来那度胺可恢复骨髓增生异常综合征对EPOα的敏感性，改善患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=888e206296e7)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961863, encodeId=41c2961863ec, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病, objectType=article, longId=210383, objectId=687e210383ae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021423/1619160180610_2110107.png, objectUrl=/article/show_article.do?id=687e210383ae, replyNumber=0, likeNumber=84, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=687e210383ae, moduleTitle=J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=687e210383ae)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961862, encodeId=10df961862b2, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：强化调理方案不能改善高危型AML/MDS老年患者allo-HSCT后的预后, objectType=article, longId=205037, objectId=941420503ec4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201230/1609321118477_2110107.PNG, objectUrl=/article/show_article.do?id=941420503ec4, replyNumber=0, likeNumber=85, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=941420503ec4, moduleTitle=J Clin Oncol：强化调理方案不能改善高危型AML/MDS老年患者allo-HSCT后的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=941420503ec4)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961861, encodeId=c6e9961861b4, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：R-CHOP方案+来那度胺可进一步改善新确诊DLBCL患者预后, objectType=article, longId=207043, objectId=91d820e04381, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202114/1609723502833_5295902.jpeg, objectUrl=/article/show_article.do?id=91d820e04381, replyNumber=0, likeNumber=77, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91d820e04381, moduleTitle=J Clin Oncol：R-CHOP方案+来那度胺可进一步改善新确诊DLBCL患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91d820e04381)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961860, encodeId=ce42961860bb, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=【盘点】2020年度J Clin Oncol杂志汇总（二）, objectType=article, longId=189227, objectId=eed218922eac, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/202003/20200302232121150.jpg, objectUrl=/article/show_article.do?id=eed218922eac, replyNumber=0, likeNumber=73, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eed218922eac, moduleTitle=【盘点】2020年度J Clin Oncol杂志汇总（二）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eed218922eac)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961859, encodeId=4c8d96185938, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：薄型(T1)黑色素瘤患者局部、区域和远处复发预测的新模型, objectType=article, longId=207580, objectId=77a120e5806e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021224/1614181375529_2110107.JPG, objectUrl=/article/show_article.do?id=77a120e5806e, replyNumber=0, likeNumber=77, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77a120e5806e, moduleTitle=J Clin Oncol：薄型(T1)黑色素瘤患者局部、区域和远处复发预测的新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77a120e5806e)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961858, encodeId=ac0996185863, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J clin oncol：帕唑帕尼 vs 阿霉素治疗晚期软组织肉瘤老年患者, objectType=article, longId=200533, objectId=48fb20053378, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599740382271_2110107.PNG, objectUrl=/article/show_article.do?id=48fb20053378, replyNumber=0, likeNumber=74, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48fb20053378, moduleTitle=J clin oncol：帕唑帕尼 vs 阿霉素治疗晚期软组织肉瘤老年患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48fb20053378)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961857, encodeId=ad1b96185e2b, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=【盘点】2020年度J Clin Oncol杂志回顾汇总（二）, objectType=article, longId=191265, objectId=5d82191265aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/133.jpg, objectUrl=/article/show_article.do?id=5d82191265aa, replyNumber=0, likeNumber=87, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d82191265aa, moduleTitle=【盘点】2020年度J Clin Oncol杂志回顾汇总（二）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d82191265aa)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961856, encodeId=a09996185645, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=【盘点】2020年度J Clin Oncol杂志回顾汇总（三）, objectType=article, longId=191271, objectId=2c901912e169, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/192.jpg, objectUrl=/article/show_article.do?id=2c901912e169, replyNumber=0, likeNumber=76, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c901912e169, moduleTitle=【盘点】2020年度J Clin Oncol杂志回顾汇总（三）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c901912e169)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961855, encodeId=7fbc96185550, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML, objectType=article, longId=207335, objectId=402b20e335fd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021219/1613727654002_2110107.PNG, objectUrl=/article/show_article.do?id=402b20e335fd, replyNumber=0, likeNumber=82, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=402b20e335fd, moduleTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=402b20e335fd)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961854, encodeId=334496185403, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：吉非替尼辅助治疗EGFR突变型NSCLC的5年预后, objectType=article, longId=204877, objectId=93f62048e720, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/atrial-fibrillation-s13-photo-of-echocardiography.jpg, objectUrl=/article/show_article.do?id=93f62048e720, replyNumber=0, likeNumber=0, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93f62048e720, moduleTitle=J Clin Oncol：吉非替尼辅助治疗EGFR突变型NSCLC的5年预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93f62048e720)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961853, encodeId=4a8b96185341, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle= J Clin Oncol：纳武单抗治疗晚期NSCLC的5年随访预后仍明显优于多西他赛！, objectType=article, longId=205997, objectId=a83520599eec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021120/1611072914001_5295905.jpg, objectUrl=/article/show_article.do?id=a83520599eec, replyNumber=0, likeNumber=85, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a83520599eec, moduleTitle= J Clin Oncol：纳武单抗治疗晚期NSCLC的5年随访预后仍明显优于多西他赛！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a83520599eec)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961852, encodeId=dcf79618521b, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：纳武单抗联合伊匹单抗用作广泛性疾病小细胞肺癌维持疗法, objectType=article, longId=208208, objectId=1acc2082087f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202139/1615284438004_2110107.PNG, objectUrl=/article/show_article.do?id=1acc2082087f, replyNumber=0, likeNumber=73, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1acc2082087f, moduleTitle=J Clin Oncol：纳武单抗联合伊匹单抗用作广泛性疾病小细胞肺癌维持疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1acc2082087f)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961851, encodeId=d251961851a5, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=Int J Clin Oncol：4天MEA治疗绒癌和高危GTN的疗效, objectType=article, longId=196673, objectId=2e7b1966e372, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/097.jpg, objectUrl=/article/show_article.do?id=2e7b1966e372, replyNumber=0, likeNumber=60, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e7b1966e372, moduleTitle=Int J Clin Oncol：4天MEA治疗绒癌和高危GTN的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e7b1966e372)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961850, encodeId=01bc961850c2, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=Int J Clin Oncol：PembrolizumabVS化疗治疗复发性晚期尿道癌的疗效, objectType=article, longId=198492, objectId=2b63198492b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/147963-medical-pills-capsules.jpg, objectUrl=/article/show_article.do?id=2b63198492b1, replyNumber=0, likeNumber=75, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b63198492b1, moduleTitle=Int J Clin Oncol：PembrolizumabVS化疗治疗复发性晚期尿道癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b63198492b1)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961849, encodeId=bd4d96184911, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS, objectType=article, longId=206018, objectId=3311206018ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/501.jpg, objectUrl=/article/show_article.do?id=3311206018ec, replyNumber=0, likeNumber=95, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3311206018ec, moduleTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3311206018ec)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961848, encodeId=5988961848bd, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌, objectType=article, longId=206571, objectId=f4692065e14a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021124/1611502379431_2020535.jpg, objectUrl=/article/show_article.do?id=f4692065e14a, replyNumber=0, likeNumber=56, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4692065e14a, moduleTitle=J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4692065e14a)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=961847, encodeId=f29796184ed9, content=<a href='/topic/show?id=11cf104251a3' target=_blank style='color:#2F92EE;'>#J Clin Oncol#</a>点击查看更多该期刊内容, objectTitle=J Clin Oncol：强化局部放疗可改善局限性前列腺癌患者的疾病控制, objectType=article, longId=206404, objectId=08a1206404fa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021129/1611907017447_2467676.PNG, objectUrl=/article/show_article.do?id=08a1206404fa, replyNumber=0, likeNumber=66, createdTime=2021-04-30, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08a1206404fa, moduleTitle=J Clin Oncol：强化局部放疗可改善局限性前列腺癌患者的疾病控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08a1206404fa)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] MedSciZeng

J Clin Oncol

2021-04-25

(审核中...)

前往app查看评论内容

#J Clin Oncol#：#长春新碱#-#拓扑替康#-#环磷酰胺#用于非转移性#尤文氏肉瘤#初始治疗的III期临床试验结果，#尤文肉瘤# (EWS) 是一种罕见的#儿童恶性肿瘤#

J Clin Oncol：长春新碱-拓扑替康-环磷酰胺用于非转移性尤文氏肉瘤初始治疗的III期临床试验结果

2022-09-20

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

Int J Clin Oncol：研究肯定pertuzumab在日本患者中的疗效，支持其在日本患者人群中的继续研究

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：来那度胺可恢复骨髓增生异常综合征对EPOα的敏感性，改善患者预后

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：强化调理方案不能改善高危型AML/MDS老年患者allo-HSCT后的预后

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：R-CHOP方案+来那度胺可进一步改善新确诊DLBCL患者预后

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

【盘点】2020年度J Clin Oncol杂志汇总（二）

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：薄型(T1)黑色素瘤患者局部、区域和远处复发预测的新模型

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J clin oncol：帕唑帕尼 vs 阿霉素治疗晚期软组织肉瘤老年患者

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

【盘点】2020年度J Clin Oncol杂志回顾汇总（二）

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

【盘点】2020年度J Clin Oncol杂志回顾汇总（三）

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：吉非替尼辅助治疗EGFR突变型NSCLC的5年预后

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：纳武单抗治疗晚期NSCLC的5年随访预后仍明显优于多西他赛！

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：纳武单抗联合伊匹单抗用作广泛性疾病小细胞肺癌维持疗法

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

Int J Clin Oncol：4天MEA治疗绒癌和高危GTN的疗效

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

Int J Clin Oncol：PembrolizumabVS化疗治疗复发性晚期尿道癌的疗效

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌

2021-04-30

(审核中...)

前往app查看评论内容

#J Clin Oncol#点击查看更多该期刊内容

J Clin Oncol：强化局部放疗可改善局限性前列腺癌患者的疾病控制

2021-04-30

科室
- - 订阅+
  - 更多科室
工具
服务